Uemura, H., Masumori, N., Takahashi, S., Hosono, M., Kinuya, S., Sunaya, T., . . . Kakehi, Y. (2021). Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: Exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents. Int J Clin Oncol.

Uemura, Hirotsugu, Naoya Masumori, Shunji Takahashi, Makoto Hosono, Seigo Kinuya, Toshiyuki Sunaya, Tomoyo Horio, Yutaka Okayama, and Yoshiyuki Kakehi. "Real-world Safety and Effectiveness of Radium-223 in Japanese Patients With Castration-resistant Prostate Cancer (CRPC) and Bone Metastasis: Exploratory Analysis, Based On the Results of Post-marketing Surveillance, According to Prior Chemotherapy Status and in Patients Without Concomitant Use of Second-generation Androgen-receptor Axis-targeted Agents." Int J Clin Oncol 2021.

Uemura, Hirotsugu, et al. "Real-world Safety and Effectiveness of Radium-223 in Japanese Patients With Castration-resistant Prostate Cancer (CRPC) and Bone Metastasis: Exploratory Analysis, Based On the Results of Post-marketing Surveillance, According to Prior Chemotherapy Status and in Patients Without Concomitant Use of Second-generation Androgen-receptor Axis-targeted Agents." Int J Clin Oncol 2021.